| Finlay Institute | |
| Established: | 1991 |
| Staff: | 970 (2014)[1] |
| Address: | Avenida 21 No. 19810 |
| City: | Havana |
| Country: | Cuba |
| Coordinates: | 23.0731°N -82.4576°W |
The Finlay Institute is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[2]
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[4]